Immunogenetics

, Volume 68, Issue 8, pp 577–596 | Cite as

Donor-unrestricted T cells in the human CD1 system

Review

Abstract

The CD1 and MHC systems are specialized for lipid and peptide display, respectively. Here, we review evidence showing how cellular CD1a, CD1b, CD1c, and CD1d proteins capture and display many cellular lipids to T cell receptors (TCRs). Increasing evidence shows that CD1-reactive T cells operate outside two classical immunogenetic concepts derived from the MHC paradigm. First, because CD1 proteins are non-polymorphic in human populations, T cell responses are not restricted to the donor’s genetic background. Second, the simplified population genetics of CD1 antigen-presenting molecules can lead to simplified patterns of TCR usage. As contrasted with donor-restricted patterns of MHC-TCR interaction, the donor-unrestricted nature of CD1-TCR interactions raises the prospect that lipid agonists and antagonists of T cells could be developed.

Keywords

CD1 Lipid antigens T cell receptor A’ roof Autoreactivity Donor-unrestricted T cells 

Notes

Acknowledgments

This work is supported by the Bill and Melinda Gates Foundation, the Tuberculosis Research Unit Network (TBRU-N) (Grants AI049313, AI111224, AR048632 and AI115358). The authors are grateful for the discussions of the donor-unrestricted T cell working group of the Consortium for Tuberculosis Vaccine Development.

References

  1. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, Taniguchi M, Grusby MJ, DeKruyff RH, Umetsu DT (2003) Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 9:582–588PubMedCrossRefGoogle Scholar
  2. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, DeKruyff RH, Umetsu DT (2006) CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 354:1117–1129PubMedCrossRefGoogle Scholar
  3. An D, Oh SF, Olszak T, Neves JF, Avci FY, Erturk-Hasdemir D, Lu X, Zeissig S, Blumberg RS, Kasper DL (2014) Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 156:123–133PubMedPubMedCentralCrossRefGoogle Scholar
  4. Arrenberg P, Halder R, Dai Y, Maricic I, Kumar V (2010) Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid. Proc Natl Acad Sci U S A 107:10984–10989PubMedPubMedCentralCrossRefGoogle Scholar
  5. Aruffo A, Seed B (1989) Expression of cDNA clones encoding the thymocyte antigens CD1a, b, c demonstrates a hierarchy of exclusion in fibroblasts. J Immunol 143:1723–1730PubMedGoogle Scholar
  6. Ayala Garcia MA, Gonzalez Yebra B, Lopez Flores AL, Guani Guerra E (2012) The major histocompatibility complex in transplantation. J Transplant 2012:842141PubMedPubMedCentralCrossRefGoogle Scholar
  7. Bai L, Sagiv Y, Liu Y, Freigang S, Yu KO, Teyton L, Porcelli SA, Savage PB, Bendelac A (2009) Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer. Proc Natl Acad Sci U S A 106:10254–10259PubMedPubMedCentralCrossRefGoogle Scholar
  8. Bai L, Picard D, Anderson B, Chaudhary V, Luoma A, Jabri B, Adams EJ, Savage PB, Bendelac A (2012) The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vdelta1 TCR. Eur J Immunol 42:2505–2510PubMedPubMedCentralCrossRefGoogle Scholar
  9. Bandyopadhyay K, Marrero I, Kumar V (2016) NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol 13:337–346PubMedPubMedCentralCrossRefGoogle Scholar
  10. Barral DC, Brenner MB (2007) CD1 antigen presentation: how it works. Nat Rev Immunol 7:929–941PubMedCrossRefGoogle Scholar
  11. Batuwangala T, Shepherd D, Gadola SD, Gibson KJ, Zaccai NR, Fersht AR, Besra GS, Cerundolo V, Jones EY (2004) The crystal structure of human CD1b with a bound bacterial glycolipid. J Immunol 172:2382–2388PubMedCrossRefGoogle Scholar
  12. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB (1994) Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372:691–694PubMedCrossRefGoogle Scholar
  13. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR (1995) CD1 recognition by mouse NK1+ T lymphocytes. Science 268:863–865PubMedCrossRefGoogle Scholar
  14. Birkholz A, Nemcovic M, Yu ED, Girardi E, Wang J, Khurana A, Pauwels N, Farber E, Chitale S, Franck RW, Tsuji M, Howell A, Van Calenbergh S, Kronenberg M, Zajonc DM (2015) Lipid and carbohydrate modifications of alpha-galactosylceramide differently influence mouse and human type I natural killer T cell activation. J Biol Chem 290:17206–17217PubMedPubMedCentralCrossRefGoogle Scholar
  15. Birkinshaw RW, Pellicci DG, Cheng TY, Keller AN, Sandoval-Romero M, Gras S, de Jong A, Uldrich AP, Moody DB, Godfrey DI, Rossjohn J (2015) Alphabeta T cell antigen receptor recognition of CD1a presenting self lipid ligands. Nat Immunol 16:258–266PubMedCrossRefGoogle Scholar
  16. Blum JS, Wearsch PA, Cresswell P (2013) Pathways of antigen processing. Annu Rev Immunol 31:443–473PubMedPubMedCentralCrossRefGoogle Scholar
  17. Borg NA, Wun KS, Kjer-Nielsen L, Wilce MC, Pellicci DG, Koh R, Besra GS, Bharadwaj M, Godfrey DI, McCluskey J, Rossjohn J (2007) CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448:44–49PubMedCrossRefGoogle Scholar
  18. Boudinot P, Mondot S, Jouneau L, Teyton L, Lefranc MP, Lantz O (2016) Restricting nonclassical MHC genes coevolve with TRAV genes used by innate-like T cells in mammals. Proc Natl Acad Sci U S A 113:E2983–E2992PubMedCrossRefGoogle Scholar
  19. Brennan PJ, Brigl M, Brenner MB (2013) Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 13:101–117PubMedCrossRefGoogle Scholar
  20. Brigl M, Brenner MB (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22:817–890PubMedCrossRefGoogle Scholar
  21. Brigl M, van den Elzen P, Chen X, Meyers JH, Wu D, Wong CH, Reddington F, Illarianov PA, Besra GS, Brenner MB, Gumperz JE (2006) Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol 176:3625–3634PubMedCrossRefGoogle Scholar
  22. Briken V, Jackman RM, Watts GF, Rogers RA, Porcelli SA (2000) Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med 192:281–288PubMedPubMedCentralCrossRefGoogle Scholar
  23. Briken V, Jackman RM, Dasgupta S, Hoening S, Porcelli SA (2002) Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J 21:825–834PubMedPubMedCentralCrossRefGoogle Scholar
  24. Brossay L, Tangri S, Bix M, Cardell S, Locksley R, Kronenberg M (1998) Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets. J Immunol 160:3681–3688PubMedGoogle Scholar
  25. Brozovic S, Nagaishi T, Yoshida M, Betz S, Salas A, Chen D, Kaser A, Glickman J, Kuo T, Little A, Morrison J, Corazza N, Kim JY, Colgan SP, Young SG, Exley M, Blumberg RS (2004) CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med 10:535–539PubMedCrossRefGoogle Scholar
  26. Cernadas M, Cavallari M, Watts G, Mori L, De Libero G, Brenner MB (2010) Early recycling compartment trafficking of CD1a is essential for its intersection and presentation of lipid antigens. J Immunol 184:1235–1241PubMedCrossRefGoogle Scholar
  27. Chang DH, Deng H, Matthews P, Krasovsky J, Ragupathi G, Spisek R, Mazumder A, Vesole DH, Jagannath S, Dhodapkar MV (2008) Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer. Blood 112:1308–1316PubMedPubMedCentralCrossRefGoogle Scholar
  28. Cheng TY, Relloso M, Van Rhijn I, Young DC, Besra GS, Briken V, Zajonc DM, Wilson IA, Porcelli S, Moody DB (2006) Role of lipid trimming and CD1 groove size in cellular antigen presentation. EMBO J 25:2989–2999PubMedPubMedCentralCrossRefGoogle Scholar
  29. Chiu YH, Jayawardena J, Weiss A, Lee D, Park SH, Dautry-Varsat A, Bendelac A (1999) Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 189:103–110PubMedPubMedCentralCrossRefGoogle Scholar
  30. Chiu YH, Park SH, Benlagha K, Forestier C, Jayawardena-Wolf J, Savage PB, Teyton L, Bendelac A (2002) Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat Immunol 3:55–60PubMedCrossRefGoogle Scholar
  31. Cohen NR, Brennan PJ, Shay T, Watts GF, Brigl M, Kang J, Brenner MB (2013) Shared and distinct transcriptional programs underlie the hybrid nature of iNKT cells. Nat Immunol 14:90–99PubMedCrossRefGoogle Scholar
  32. Cox D, Fox L, Tian R, Bardet W, Skaley M, Mojsilovic D, Gumperz J, Hildebrand W (2009) Determination of cellular lipids bound to human CD1d molecules. PLoS One 4:e5325PubMedPubMedCentralCrossRefGoogle Scholar
  33. Crosby CM, Kronenberg M (2016) Invariant natural killer T cells: front line fighters in the war against pathogenic microbes. Immunogenetics. doi: 10.1007/s00251-016-0933-y.
  34. Cui K, Yan G, Xu C, Chen Y, Wang J, Zhou R, Bai L, Lian Z, Wei H, Sun R, Tian Z (2015) Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1beta in mice. J Hepatol 62:1311–1318PubMedCrossRefGoogle Scholar
  35. de Jong A, Pena-Cruz V, Cheng TY, Clark RA, Van Rhijn I, Moody DB (2010) CD1a-autoreactive T cells are a normal component of the human alphabeta T cell repertoire. Nat Immunol 11:1102–1109PubMedPubMedCentralCrossRefGoogle Scholar
  36. de Jong A, Cheng TY, Huang S, Gras S, Birkinshaw RW, Kasmar AG, Van Rhijn I, Pena-Cruz V, Ruan DT, Altman JD, Rossjohn J, Moody DB (2014) CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens. Nat Immunol 15:177–185PubMedCrossRefGoogle Scholar
  37. de la Salle H, Mariotti S, Angenieux C, Gilleron M, Garcia-Alles LF, Malm D, Berg T, Paoletti S, Maitre B, Mourey L, Salamero J, Cazenave JP, Hanau D, Mori L, Puzo G, De Libero G (2005) Assistance of microbial glycolipid antigen processing by CD1e. Science 310:1321–1324PubMedCrossRefGoogle Scholar
  38. de Lalla C, Lepore M, Piccolo FM, Rinaldi A, Scelfo A, Garavaglia C, Mori L, De Libero G, Dellabona P, Casorati G (2011) High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells. Eur J Immunol 41:602–610PubMedCrossRefGoogle Scholar
  39. De Libero G, Moran AP, Gober HJ, Rossy E, Shamshiev A, Chelnokova O, Mazorra Z, Vendetti S, Sacchi A, Prendergast MM, Sansano S, Tonevitsky A, Landmann R, Mori L (2005) Bacterial infections promote T cell recognition of self-glycolipids. Immunity 22:763–772PubMedCrossRefGoogle Scholar
  40. Dellabona P, Consonni M, de Lalla C, Casorati G (2015) Group 1 CD1-restricted T cells and the pathophysiological implications of self-lipid antigen recognition. Tissue Antigens 86:393–405PubMedCrossRefGoogle Scholar
  41. Denzin LK, Cresswell P (1995) HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82:155–165PubMedCrossRefGoogle Scholar
  42. Dougan SK, Salas A, Rava P, Agyemang A, Kaser A, Morrison J, Khurana A, Kronenberg M, Johnson C, Exley M, Hussain MM, Blumberg RS (2005) Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med 202:529–539PubMedPubMedCentralCrossRefGoogle Scholar
  43. Dougan SK, Kaser A, Blumberg RS (2007a) CD1 expression on antigen-presenting cells. Curr Top Microbiol Immunol 314:113–141PubMedGoogle Scholar
  44. Dougan SK, Rava P, Hussain MM, Blumberg RS (2007b) MTP regulated by an alternate promoter is essential for NKT cell development. J Exp Med 204:533–545PubMedPubMedCentralCrossRefGoogle Scholar
  45. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D, Milder M, Le Bourhis L, Soudais C, Treiner E, Lantz O (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117:1250–1259PubMedCrossRefGoogle Scholar
  46. Facciotti F, Ramanjaneyulu GS, Lepore M, Sansano S, Cavallari M, Kistowska M, Forss-Petter S, Ni G, Colone A, Singhal A, Berger J, Xia C, Mori L, De Libero G (2012) Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol 13:474–480PubMedCrossRefGoogle Scholar
  47. Felio K, Nguyen H, Dascher CC, Choi HJ, Li S, Zimmer MI, Colmone A, Moody DB, Brenner MB, Wang CR (2009) CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. J Exp Med 206:2497–2509PubMedPubMedCentralCrossRefGoogle Scholar
  48. Fowlkes BJ, Kruisbeek AM, Ton-That H, Weston MA, Coligan JE, Schwartz RH, Pardoll DM (1987) A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family. Nature 329:251–254PubMedCrossRefGoogle Scholar
  49. Fox CB, Haensler J (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Rev Vaccines 12:747–758PubMedCrossRefGoogle Scholar
  50. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM (2003) Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198:267–279PubMedPubMedCentralCrossRefGoogle Scholar
  51. Gadola SD, Zaccai NR, Harlos K, Shepherd D, Castro-Palomino JC, Ritter G, Schmidt RR, Jones EY, Cerundolo V (2002) Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat Immunol 3:721–726PubMedCrossRefGoogle Scholar
  52. Gao B, Radaeva S, Park O (2009) Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 86:513–528PubMedPubMedCentralCrossRefGoogle Scholar
  53. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134–141PubMedCrossRefGoogle Scholar
  54. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA (1996) An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274:209–219PubMedCrossRefGoogle Scholar
  55. Garcia-Alles LF, Versluis K, Maveyraud L, Vallina AT, Sansano S, Bello NF, Gober HJ, Guillet V, de la Salle H, Puzo G, Mori L, Heck AJ, De Libero G, Mourey L (2006) Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J 25:3684–3692PubMedPubMedCentralCrossRefGoogle Scholar
  56. Garcia-Alles LF, Collmann A, Versluis C, Lindner B, Guiard J, Maveyraud L, Huc E, Im JS, Sansano S, Brando T, Julien S, Prandi J, Gilleron M, Porcelli SA, de la Salle H, Heck AJ, Mori L, Puzo G, Mourey L, De Libero G (2011) Structural reorganization of the antigen-binding groove of human CD1b for presentation of mycobacterial sulfoglycolipids. Proc Natl Acad Sci U S A 108:17755–17760PubMedPubMedCentralCrossRefGoogle Scholar
  57. Gherardin NA, Keller AN, Woolley RE, Le Nours J, Ritchie DS, Neeson PJ, Birkinshaw RW, Eckle SB, Waddington JN, Liu L, Fairlie DP, Uldrich AP, Pellicci DG, McCluskey J, Godfrey DI, Rossjohn J (2016) Diversity of T cells restricted by the MHC class I-related molecule MR1 facilitates differential antigen recognition. Immunity 44:32–45PubMedCrossRefGoogle Scholar
  58. Gilleron M, Stenger S, Mazorra Z, Wittke F, Mariotti S, Bohmer G, Prandi J, Mori L, Puzo G, De Libero G (2004) Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 199:649–659PubMedPubMedCentralCrossRefGoogle Scholar
  59. Godfrey DI, Kronenberg M (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114:1379–1388PubMedPubMedCentralCrossRefGoogle Scholar
  60. Gold MC, McLaren JE, Reistetter JA, Smyk-Pearson S, Ladell K, Swarbrick GM, Yu YY, Hansen TH, Lund O, Nielsen M, Gerritsen B, Kesmir C, Miles JJ, Lewinsohn DA, Price DA, Lewinsohn DM (2014) MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage. J Exp Med 211:1601–1610PubMedPubMedCentralCrossRefGoogle Scholar
  61. Grant EP, Degano M, Rosat JP, Stenger S, Modlin RL, Wilson IA, Porcelli SA, Brenner MB (1999) Molecular recognition of lipid antigens by T cell receptors. J Exp Med 189:195–205PubMedPubMedCentralCrossRefGoogle Scholar
  62. Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, Porcelli SA, Cardell S, Brenner MB, Behar SM (2000) Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211–221PubMedCrossRefGoogle Scholar
  63. Halder RC, Aguilera C, Maricic I, Kumar V (2007) Type II NKT cell-mediated energy induction in type I NKT cells prevents inflammatory liver disease. J Clin Invest 117:2302–2312PubMedPubMedCentralCrossRefGoogle Scholar
  64. Han M, Hannick LI, DiBrino M, Robinson MA (1999) Polymorphism of human CD1 genes. Tissue Antigens 54:122–127PubMedCrossRefGoogle Scholar
  65. Hansen TH, Huang S, Arnold PL, Fremont DH (2007) Patterns of nonclassical MHC antigen presentation. Nat Immunol 8:563–568PubMedCrossRefGoogle Scholar
  66. Hansen TH, Connolly JM, Gould KG, Fremont DH (2010) Basic and translational applications of engineered MHC class I proteins. Trends Immunol 31:363–369PubMedPubMedCentralCrossRefGoogle Scholar
  67. Hiromatsu K, Dascher CC, LeClair KP, Sugita M, Furlong ST, Brenner MB, Porcelli SA (2002) Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J Immunol 169:330–339PubMedCrossRefGoogle Scholar
  68. Huang S, Gilfillan S, Cella M, Miley MJ, Lantz O, Lybarger L, Fremont DH, Hansen TH (2005) Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem 280:21183–21193PubMedCrossRefGoogle Scholar
  69. Huang S, Cheng TY, Young DC, Layre E, Madigan CA, Shires J, Cerundolo V, Altman JD, Moody DB (2011) Discovery of deoxyceramides and diacylglycerols as CD1b scaffold lipids among diverse groove-blocking lipids of the human CD1 system. Proc Natl Acad Sci U S A 108:19335–19340PubMedPubMedCentralCrossRefGoogle Scholar
  70. Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, Rea TH, Brennan PJ, Belisle JT, Blauvelt A, Porcelli SA, Modlin RL (2004) Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 113:701–708PubMedPubMedCentralCrossRefGoogle Scholar
  71. Im JS, Arora P, Bricard G, Molano A, Venkataswamy MM, Baine I, Jerud ES, Goldberg MF, Baena A, Yu KO, Ndonye RM, Howell AR, Yuan W, Cresswell P, Chang YT, Illarionov PA, Besra GS, Porcelli SA (2009) Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 30:888–898PubMedPubMedCentralCrossRefGoogle Scholar
  72. Imai K, Kanno M, Kimoto H, Shigemoto K, Yamamoto S, Taniguchi M (1986) Sequence and expression of transcripts of the T-cell antigen receptor alpha-chain gene in a functional, antigen-specific suppressor-T-cell hybridoma. Proc Natl Acad Sci U S A 83:8708–8712PubMedPubMedCentralCrossRefGoogle Scholar
  73. Jackman RM, Stenger S, Lee A, Moody DB, Rogers RA, Niazi KR, Sugita M, Modlin RL, Peters PJ, Porcelli SA (1998) The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 8:341–351PubMedCrossRefGoogle Scholar
  74. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A (2001) CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15:897–908PubMedCrossRefGoogle Scholar
  75. Ji Y, Sun S, Xu A, Bhargava P, Yang L, Lam KS, Gao B, Lee CH, Kersten S, Qi L (2012) Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 287:13561–13571PubMedPubMedCentralCrossRefGoogle Scholar
  76. Jones EY, Fugger L, Strominger JL, Siebold C (2006) MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 6:271–282PubMedCrossRefGoogle Scholar
  77. Joyce S, Woods AS, Yewdell JW, Bennink JR, De Silva AD, Boesteanu A, Balk SP, Cotter RJ, Brutkiewicz RR (1998) Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279:1541–1544PubMedCrossRefGoogle Scholar
  78. Kain L, Webb B, Anderson BL, Deng S, Holt M, Costanzo A, Zhao M, Self K, Teyton A, Everett C, Kronenberg M, Zajonc DM, Bendelac A, Savage PB, Teyton L (2014) The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity 41:543–554PubMedPubMedCentralCrossRefGoogle Scholar
  79. Kang SJ, Cresswell P (2004) Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 5:175–181PubMedCrossRefGoogle Scholar
  80. Kasmar A, Van Rhijn I, Moody DB (2009) The evolved functions of CD1 during infection. Curr Opin Immunol 21:397–403PubMedPubMedCentralCrossRefGoogle Scholar
  81. Kasmar AG, van Rhijn I, Cheng TY, Turner M, Seshadri C, Schiefner A, Kalathur RC, Annand JW, de Jong A, Shires J, Leon L, Brenner M, Wilson IA, Altman JD, Moody DB (2011) CD1b tetramers bind {alpha}{beta} T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 208:1741–1747PubMedPubMedCentralCrossRefGoogle Scholar
  82. Kasmar AG, Van Rhijn I, Magalhaes KG, Young DC, Cheng TY, Turner MT, Schiefner A, Kalathur RC, Wilson IA, Bhati M, Gras S, Birkinshaw RW, Tan LL, Rossjohn J, Shires J, Jakobsen S, Altman JD, Moody DB (2013) Cutting edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo. J Immunol 191:4499–4503PubMedCrossRefGoogle Scholar
  83. Kasprowicz VO, Cheng TY, Ndung’u T, Sunpath H, Moody DB, Kasmar AG (2016) HIV disrupts human T cells that target mycobacterial glycolipids. J Infect Dis 213:628–633PubMedCrossRefGoogle Scholar
  84. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278:1626–1629PubMedCrossRefGoogle Scholar
  85. Kawasaki N, Rillahan CD, Cheng TY, Van Rhijn I, Macauley MS, Moody DB, Paulson JC (2014) Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation. J Immunol 193:1560–1566PubMedPubMedCentralCrossRefGoogle Scholar
  86. Kim EY, Lynch L, Brennan PJ, Cohen NR, Brenner MB (2015) The transcriptional programs of iNKT cells. Semin Immunol 27:26–32PubMedCrossRefGoogle Scholar
  87. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520–525PubMedCrossRefGoogle Scholar
  88. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, Bhati M, Chen Z, Kostenko L, Reantragoon R, Williamson NA, Purcell AW, Dudek NL, McConville MJ, O’Hair RA, Khairallah GN, Godfrey DI, Fairlie DP, Rossjohn J, McCluskey J (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491(7426):717–723PubMedGoogle Scholar
  89. Kobayashi C, Shiina T, Tokioka A, Hattori Y, Komori T, Kobayashi-Miura M, Takizawa T, Takahara K, Inaba K, Inoko H, Takeya M, Dranoff G, Sugita M (2012) GM-CSF-independent CD1a expression in epidermal Langerhans cells: evidence from human CD1A genome-transgenic mice. J investigative dermatol 132:241–244CrossRefGoogle Scholar
  90. Lalvani A, Pareek M (2010) A 100 year update on diagnosis of tuberculosis infection. Br Med Bull 93:69–84PubMedCrossRefGoogle Scholar
  91. Lawton AP, Prigozy TI, Brossay L, Pei B, Khurana A, Martin D, Zhu T, Spate K, Ozga M, Honing S, Bakke O, Kronenberg M (2005) The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms. J Immunol 174:3179–3186PubMedCrossRefGoogle Scholar
  92. Layre E, Collmann A, Bastian M, Mariotti S, Czaplicki J, Prandi J, Mori L, Stenger S, De Libero G, Puzo G, Gilleron M (2009) Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells. Chemist biol 16:82–92CrossRefGoogle Scholar
  93. Lazzarini A, Macchiarulo A, Floridi A, Coletti A, Cataldi S, Codini M, Lazzarini R, Bartoccini E, Cascianelli G, Ambesi-Impiombato FS, Beccari T, Curcio F, Albi E (2015) Very-long-chain fatty acid sphingomyelin in nuclear lipid microdomains of hepatocytes and hepatoma cells: can the exchange from C24:0 to C16:0 affect signal proteins and vitamin D receptor? Mol Biol Cell 26:2418–2425PubMedPubMedCentralCrossRefGoogle Scholar
  94. Leon L, Tatituri RV, Grenha R, Sun Y, Barral DC, Minnaard AJ, Bhowruth V, Veerapen N, Besra GS, Kasmar A, Peng W, Moody DB, Grabowski GA, Brenner MB (2012) Saposins utilize two strategies for lipid transfer and CD1 antigen presentation. Proc Natl Acad Sci U S A 109:4357–4364PubMedPubMedCentralCrossRefGoogle Scholar
  95. Lepore M, de Lalla C, Gundimeda SR, Gsellinger H, Consonni M, Garavaglia C, Sansano S, Piccolo F, Scelfo A, Haussinger D, Montagna D, Locatelli F, Bonini C, Bondanza A, Forcina A, Li Z, Ni G, Ciceri F, Jeno P, Xia C, Mori L, Dellabona P, Casorati G, De Libero G (2014) A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med 211:1363–1377PubMedPubMedCentralCrossRefGoogle Scholar
  96. Li Y, Girardi E, Wang J, Yu ED, Painter GF, Kronenberg M, Zajonc DM (2010) The Valpha14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J Exp Med 207:2383–2393PubMedPubMedCentralCrossRefGoogle Scholar
  97. Luoma AM, Castro CD, Mayassi T, Bembinster LA, Bai L, Picard D, Anderson B, Scharf L, Kung JE, Sibener LV, Savage PB, Jabri B, Bendelac A, Adams EJ (2013) Crystal structure of Vdelta1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T cells. Immunity 39:1032–1042PubMedCrossRefGoogle Scholar
  98. Ly D, Moody DB (2014) The CD1 size problem: lipid antigens, ligands, and scaffolds. Cell Mol Life Sci 71:3069–3079PubMedPubMedCentralCrossRefGoogle Scholar
  99. Ly D, Kasmar AG, Cheng TY, de Jong A, Huang S, Roy S, Bhatt A, van Summeren RP, Altman JD, Jacobs WR Jr, Adams EJ, Minnaard AJ, Porcelli SA, Moody DB (2013) CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens. J Exp Med 210:729–741PubMedPubMedCentralCrossRefGoogle Scholar
  100. Lynch L, Nowak M, Varghese B, Clark J, Hogan AE, Toxavidis V, Balk SP, O’Shea D, O’Farrelly C, Exley MA (2012) Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37:574–587PubMedPubMedCentralCrossRefGoogle Scholar
  101. Lynch L, Michelet X, Zhang S, Brennan PJ, Moseman A, Lester C, Besra G, Vomhof-Dekrey EE, Tighe M, Koay HF, Godfrey DI, Leadbetter EA, Sant’Angelo DB, von Andrian U, Brenner MB (2014) Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T cells and macrophages in adipose tissue. Nat Immunol 16(1):85–95PubMedPubMedCentralCrossRefGoogle Scholar
  102. Macho-Fernandez E, Brigl M (2015) The extended family of CD1d-restricted NKT cells: sifting through a mixed bag of TCRs, antigens, and functions. Front Immunol 6:362PubMedPubMedCentralCrossRefGoogle Scholar
  103. Madden DR, Gorga JC, Strominger JL, Wiley DC (1991) The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:321–325PubMedCrossRefGoogle Scholar
  104. Mallevaey T, Clarke AJ, Scott-Browne JP, Young MH, Roisman LC, Pellicci DG, Patel O, Vivian JP, Matsuda JL, McCluskey J, Godfrey DI, Marrack P, Rossjohn J, Gapin L (2011) A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34:315–326PubMedPubMedCentralCrossRefGoogle Scholar
  105. Manolova V, Kistowska M, Paoletti S, Baltariu GM, Bausinger H, Hanau D, Mori L, De Libero G (2006) Functional CD1a is stabilized by exogenous lipids. Eur J Immunol 36:1083–1092PubMedCrossRefGoogle Scholar
  106. Mansour S, Tocheva AS, Cave-Ayland C, Machelett MM, Sander B, Lissin NM, Molloy PE, Baird MS, Stubs G, Schroder NW, Schumann RR, Rademann J, Postle AD, Jakobsen BK, Marshall BG, Gosain R, Elkington PT, Elliott T, Skylaris CK, Essex JW, Tews I, Gadola SD (2016) Cholesteryl esters stabilize human CD1c conformations for recognition by self-reactive T cells. Proc Natl Acad Sci U S A 113:E1266–E1275PubMedPubMedCentralCrossRefGoogle Scholar
  107. Maricic I, Sheng H, Marrero I, Seki E, Kisseleva T, Chaturvedi S, Molle N, Mathews SA, Gao B, Kumar V (2015) Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology 61:1357–1369PubMedPubMedCentralCrossRefGoogle Scholar
  108. Martin E, Treiner E, Duban L, Guerri L, Laude H, Toly C, Premel V, Devys A, Moura IC, Tilloy F, Cherif S, Vera G, Latour S, Soudais C, Lantz O (2009) Stepwise development of MAIT cells in mouse and human. PLoS Biol 7:e54PubMedCrossRefGoogle Scholar
  109. Mathews S, Feng D, Maricic I, Ju C, Kumar V, Gao B (2016) Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. Cell Mol Immunol 13:206–216PubMedCrossRefGoogle Scholar
  110. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525–529PubMedCrossRefGoogle Scholar
  111. McCarthy C, Shepherd D, Fleire S, Stronge VS, Koch M, Illarionov PA, Bossi G, Salio M, Denkberg G, Reddington F, Tarlton A, Reddy BG, Schmidt RR, Reiter Y, Griffiths GM, van der Merwe PA, Besra GS, Jones EY, Batista FD, Cerundolo V (2007) The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med 204:1131–1144PubMedPubMedCentralCrossRefGoogle Scholar
  112. Miley MJ, Messaoudi I, Metzner BM, Wu Y, Nikolich-Zugich J, Fremont DH (2004) Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution. J Exp Med 200:1445–1454PubMedPubMedCentralCrossRefGoogle Scholar
  113. Mohan JF, Unanue ER (2012) Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat Rev Immunol 12:721–728PubMedCrossRefGoogle Scholar
  114. Moody DB, Porcelli SA (2003) Intracellular pathways of CD1 antigen presentation. Nat Rev Immunol 3:11–22PubMedCrossRefGoogle Scholar
  115. Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, Furlong ST, Ye S, Reinhold VN, Sieling PA, Modlin RL, Besra GS, Porcelli SA (1997) Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278:283–286PubMedCrossRefGoogle Scholar
  116. Moody DB, Ulrichs T, Muhlecker W, Young DC, Gurcha SS, Grant E, Rosat JP, Brenner MB, Costello CE, Besra GS, Porcelli SA (2000) CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404:884–888PubMedCrossRefGoogle Scholar
  117. Moody DB, Briken V, Cheng TY, Roura-Mir C, Guy MR, Geho DH, Tykocinski ML, Besra GS, Porcelli SA (2002) Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 3:435–442PubMedGoogle Scholar
  118. Moody DB, Zajonc DM, Wilson IA (2005) Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol 5:387–399PubMedCrossRefGoogle Scholar
  119. Moore KJ, Tabas I (2011) Macrophages in the pathogenesis of atherosclerosis. Cell 145:341–355PubMedPubMedCentralCrossRefGoogle Scholar
  120. Nair S, Boddupalli CS, Verma R, Liu J, Yang R, Pastores GM, Mistry PK, Dhodapkar MV (2015) Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation. Blood 125:1256–1271PubMedPubMedCentralCrossRefGoogle Scholar
  121. Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823–836PubMedGoogle Scholar
  122. Nikolich-Zugich J, Slifka MK, Messaoudi I (2004) The many important facets of T-cell repertoire diversity. Nat Rev Immunol 4:123–132PubMedCrossRefGoogle Scholar
  123. Olszak T, Neves JF, Dowds CM, Baker K, Glickman J, Davidson NO, Lin CS, Jobin C, Brand S, Sotlar K, Wada K, Katayama K, Nakajima A, Mizuguchi H, Kawasaki K, Nagata K, Muller W, Snapper SB, Schreiber S, Kaser A, Zeissig S, Blumberg RS (2014) Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature 509:497–502PubMedPubMedCentralCrossRefGoogle Scholar
  124. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SB, Birkinshaw R, Beddoe T, Corbett AJ, Liu L, Miles JJ, Meehan B, Reantragoon R, Sandoval-Romero ML, Sullivan LC, Brooks AG, Chen Z, Fairlie DP, McCluskey J, Rossjohn J (2013) Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun 4:2142PubMedGoogle Scholar
  125. Pearce EJ, Everts B (2015) Dendritic cell metabolism. Nat Rev Immunol 15:18–29PubMedPubMedCentralCrossRefGoogle Scholar
  126. Pellicci DG, Clarke AJ, Patel O, Mallevaey T, Beddoe T, Le Nours J, Uldrich AP, McCluskey J, Besra GS, Porcelli SA, Gapin L, Godfrey DI, Rossjohn J (2011) Recognition of beta-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat Immunol 12:827–833PubMedCrossRefGoogle Scholar
  127. Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA (1989) Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature 341:447–450PubMedCrossRefGoogle Scholar
  128. Porcelli S, Yockey CE, Brenner MB, Balk SP (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178:1–16PubMedCrossRefGoogle Scholar
  129. Prigozy TI, Sieling PA, Clemens D, Stewart PL, Behar SM, Porcelli SA, Brenner MB, Modlin RL, Kronenberg M (1997) The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6:187–197PubMedCrossRefGoogle Scholar
  130. Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, Khurana A, Natori T, Koezuka Y, Kulkarni A, Kronenberg M (2001) Glycolipid antigen processing for presentation by CD1d molecules. Science 291:664–667PubMedCrossRefGoogle Scholar
  131. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, Chen Z, Eckle SB, Uldrich AP, Birkinshaw RW, Patel O, Kostenko L, Meehan B, Kedzierska K, Liu L, Fairlie DP, Hansen TH, Godfrey DI, Rossjohn J, McCluskey J, Kjer-Nielsen L (2013) Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med 210:2305–2320PubMedPubMedCentralCrossRefGoogle Scholar
  132. Relloso M, Cheng TY, Im JS, Parisini E, Roura-Mir C, DeBono C, Zajonc DM, Murga LF, Ondrechen MJ, Wilson IA, Porcelli SA, Moody DB (2008) pH-dependent interdomain tethers of CD1b regulate its antigen capture. Immunity 28:774–786PubMedPubMedCentralCrossRefGoogle Scholar
  133. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI (2012) Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol 12:845–857PubMedPubMedCentralCrossRefGoogle Scholar
  134. Rossjohn J, Gras S, Miles JJ, Turner SJ, Godfrey DI, McCluskey J (2015) T cell antigen receptor recognition of antigen-presenting molecules. Annu Rev Immunol 33:169–200PubMedCrossRefGoogle Scholar
  135. Roy S, Ly D, Li NS, Altman JD, Piccirilli JA, Moody DB, Adams EJ (2014) Molecular basis of mycobacterial lipid antigen presentation by CD1c and its recognition by alphabeta T cells. Proc Natl Acad Sci U S A 111:E4648–E4657PubMedPubMedCentralCrossRefGoogle Scholar
  136. Roy S, Ly D, Castro CD, Li NS, Hawk AJ, Altman JD, Meredith SC, Piccirilli JA, Moody DB, Adams EJ (2016) Molecular analysis of lipid-reactive Vdelta1 gammadelta T cells identified by CD1c tetramers. J Immunol 196:1933–1942PubMedCrossRefGoogle Scholar
  137. Salio M, Cerundolo V (2015) Regulation of lipid specific and vitamin specific non-MHC restricted T cells by antigen presenting cells and their therapeutic potentials. Front Immunol 6:388PubMedPubMedCentralCrossRefGoogle Scholar
  138. Salio M, Ghadbane H, Dushek O, Shepherd D, Cypen J, Gileadi U, Aichinger MC, Napolitani G, Qi X, van der Merwe PA, Wojno J, Veerapen N, Cox LR, Besra GS, Yuan W, Cresswell P, Cerundolo V (2013) Saposins modulate human invariant natural killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation. Proc Natl Acad Sci U S A 110:E4753–E4761PubMedPubMedCentralCrossRefGoogle Scholar
  139. Salio M, Silk JD, Jones EY, Cerundolo V (2014) Biology of CD1- and MR1-restricted T cells. Annu Rev Immunol 32:323–366PubMedCrossRefGoogle Scholar
  140. Savage AK, Constantinides MG, Han J, Picard D, Martin E, Li B, Lantz O, Bendelac A (2008) The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29:391–403PubMedPubMedCentralCrossRefGoogle Scholar
  141. Scharf L, Li NS, Hawk AJ, Garzon D, Zhang T, Fox LM, Kazen AR, Shah S, Haddadian EJ, Gumperz JE, Saghatelian A, Faraldo-Gomez JD, Meredith SC, Piccirilli JA, Adams EJ (2010) The 2.5 a structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity 33:853–862PubMedPubMedCentralCrossRefGoogle Scholar
  142. Schipper HS, Rakhshandehroo M, van de Graaf SF, Venken K, Koppen A, Stienstra R, Prop S, Meerding J, Hamers N, Besra G, Boon L, Nieuwenhuis EE, Elewaut D, Prakken B, Kersten S, Boes M, Kalkhoven E (2012) Natural killer T cells in adipose tissue prevent insulin resistance. J Clin Invest 122:3343–3354PubMedPubMedCentralCrossRefGoogle Scholar
  143. Seino K, Motohashi S, Fujisawa T, Nakayama T, Taniguchi M (2006) Natural killer T cell-mediated antitumor immune responses and their clinical applications. Cancer Sci 97:807–812PubMedCrossRefGoogle Scholar
  144. Seshadri C, Thuong NT, Yen NT, Bang ND, Chau TT, Thwaites GE, Dunstan SJ, Hawn TR (2014) A polymorphism in human CD1A is associated with susceptibility to tuberculosis. Genes Immun 15:195–198PubMedPubMedCentralCrossRefGoogle Scholar
  145. Shamshiev A, Donda A, Carena I, Mori L, Kappos L, De Libero G (1999) Self glycolipids as T-cell autoantigens. Eur J Immunol 29:1667–1675PubMedCrossRefGoogle Scholar
  146. Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V (2004) Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 114:1800–1811PubMedPubMedCentralCrossRefGoogle Scholar
  147. Sprengers D, Sille FC, Derkow K, Besra GS, Janssen HL, Schott E, Boes M (2008) Critical role for CD1d-restricted invariant NKT cells in stimulating intrahepatic CD8 T-cell responses to liver antigen. Gastroenterology 134:2132–2143PubMedCrossRefGoogle Scholar
  148. Stern LJ, Wiley DC (1994) Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2:245–251Google Scholar
  149. Sugita M, Grant EP, van Donselaar E, Hsu VW, Rogers RA, Peters PJ, Brenner MB (1999) Separate pathways for antigen presentation by CD1 molecules. Immunity 11:743–752PubMedCrossRefGoogle Scholar
  150. Sugita M, van Der Wel N, Rogers RA, Peters PJ, Brenner MB (2000) CD1c molecules broadly survey the endocytic system. Proc Natl Acad Sci U S A 97:8445–8450PubMedPubMedCentralCrossRefGoogle Scholar
  151. Sugita M, Cao X, Watts GF, Rogers RA, Bonifacino JS, Brenner MB (2002) Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 16:697–706PubMedCrossRefGoogle Scholar
  152. Sullivan LC, Hoare HL, McCluskey J, Rossjohn J, Brooks AG (2006) A structural perspective on MHC class Ib molecules in adaptive immunity. Trends Immunol 27:413–420PubMedCrossRefGoogle Scholar
  153. Suri A, Lovitch SB, Unanue ER (2006) The wide diversity and complexity of peptides bound to class II MHC molecules. Curr Opin Immunol 18:70–77PubMedCrossRefGoogle Scholar
  154. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K (2000) Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 97:5498–5503PubMedPubMedCentralCrossRefGoogle Scholar
  155. Taniguchi M, Harada M, Dashtsoodol N, Kojo S (2015) Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy. Proc Jpn Acad Ser B Phys Biol Sci 91:292–304PubMedPubMedCentralCrossRefGoogle Scholar
  156. Tatituri RV, Watts GF, Bhowruth V, Barton N, Rothchild A, Hsu FF, Almeida CF, Cox LR, Eggeling L, Cardell S, Rossjohn J, Godfrey DI, Behar SM, Besra GS, Brenner MB, Brigl M (2013) Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs. Proc Natl Acad Sci U S A 110:1827–1832PubMedPubMedCentralCrossRefGoogle Scholar
  157. Telesford KM, Yan W, Ochoa-Reparaz J, Pant A, Kircher C, Christy MA, Begum-Haque S, Kasper DL, Kasper LH (2015) A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 6:234–242PubMedPubMedCentralCrossRefGoogle Scholar
  158. Thomas SY, Lilly CM, Luster AD (2006) Invariant natural killer T cells in bronchial asthma. N Engl J Med 354:2613–2616, author reply 2613–6PubMedCrossRefGoogle Scholar
  159. Thomas SY, Chyung YH, Luster AD (2010) Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma. J Allergy Clin Immunol 125:980–984PubMedPubMedCentralCrossRefGoogle Scholar
  160. Tilloy F, Treiner E, Park SH, Garcia C, Lemonnier F, de la Salle H, Bendelac A, Bonneville M, Lantz O (1999) An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals. J Exp Med 189:1907–1921PubMedPubMedCentralCrossRefGoogle Scholar
  161. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, Tilloy F, Affaticati P, Gilfillan S, Lantz O (2003) Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422:164–169PubMedCrossRefGoogle Scholar
  162. Trowsdale J, Knight JC (2013) Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet 14:301–323PubMedPubMedCentralCrossRefGoogle Scholar
  163. Uldrich AP, Patel O, Cameron G, Pellicci DG, Day EB, Sullivan LC, Kyparissoudis K, Kjer-Nielsen L, Vivian JP, Cao B, Brooks AG, Williams SJ, Illarionov P, Besra GS, Turner SJ, Porcelli SA, McCluskey J, Smyth MJ, Rossjohn J, Godfrey DI (2011) A semi-invariant V(alpha)10(+) T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat Immunol 12:616–623PubMedCrossRefGoogle Scholar
  164. Uldrich AP, Le Nours J, Pellicci DG, Gherardin NA, McPherson KG, Lim RT, Patel O, Beddoe T, Gras S, Rossjohn J, Godfrey DI (2013) CD1d-lipid antigen recognition by the gammadelta TCR. Nat Immunol 14:1137–1145PubMedCrossRefGoogle Scholar
  165. van den Elzen P, Garg S, Leon L, Brigl M, Leadbetter EA, Gumperz JE, Dascher CC, Cheng TY, Sacks FM, Illarionov PA, Besra GS, Kent SC, Moody DB, Brenner MB (2005) Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437:906–910PubMedCrossRefGoogle Scholar
  166. Van Rhijn I, Moody DB (2015) Donor unrestricted T cells: a shared human T cell response. J Immunol 195:1927–1932PubMedCrossRefGoogle Scholar
  167. Van Rhijn I, Kasmar A, de Jong A, Gras S, Bhati M, Doorenspleet ME, de Vries N, Godfrey DI, Altman JD, de Jager W, Rossjohn J, Moody DB (2013) A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat Immunol 14:706–713PubMedPubMedCentralCrossRefGoogle Scholar
  168. Van Rhijn I, Gherardin NA, Kasmar A, de Jager W, Pellicci DG, Kostenko L, Tan LL, Bhati M, Gras S, Godfrey DI, Rossjohn J, Moody DB (2014) TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T Cell repertoire. J Immunol 192:4054–4060PubMedPubMedCentralCrossRefGoogle Scholar
  169. Van Rhijn I, Godfrey DI, Rossjohn J, Moody DB (2015a) Lipid and small-molecule display by CD1 and MR1. Nat Rev Immunol 15:643–654PubMedCrossRefGoogle Scholar
  170. Van Rhijn I, van Berlo T, Hilmenyuk T, Cheng TY, Wolf BJ, Tatituri RV, Uldrich AP, Napolitani G, Cerundolo V, Altman JD, Willemsen P, Huang S, Rossjohn J, Besra GS, Brenner MB, Godfrey DI, Moody DB (2015b) Human autoreactive T cells recognize CD1b and phospholipids. Proc Natl Acad Sci U S A 113(2):380–385PubMedPubMedCentralCrossRefGoogle Scholar
  171. Venturi V, Price DA, Douek DC, Davenport MP (2008) The molecular basis for public T-cell responses? Nat Rev Immunol 8:231–238PubMedCrossRefGoogle Scholar
  172. Viale R, Ware R, Maricic I, Chaturvedi V, Kumar V (2012) NKT cell subsets can exert opposing effects in autoimmunity, tumor surveillance and inflammation. Curr Immunol Rev 8:287–296PubMedPubMedCentralCrossRefGoogle Scholar
  173. Wang J, Li Y, Kinjo Y, Mac TT, Gibson D, Painter GF, Kronenberg M, Zajonc DM (2010) Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells. Proc Natl Acad Sci U S A 107:1535–1540PubMedCrossRefGoogle Scholar
  174. Wieland Brown LC, Penaranda C, Kashyap PC, Williams BB, Clardy J, Kronenberg M, Sonnenburg JL, Comstock LE, Bluestone JA, Fischbach MA (2013) Production of alpha-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol 11:e1001610PubMedPubMedCentralCrossRefGoogle Scholar
  175. Winau F, Schwierzeck V, Hurwitz R, Remmel N, Sieling PA, Modlin RL, Porcelli SA, Brinkmann V, Sugita M, Sandhoff K, Kaufmann SH, Schaible UE (2004) Saposin C is required for lipid presentation by human CD1b. Nat Immunol 5:169–174PubMedCrossRefGoogle Scholar
  176. Wu D, Zajonc DM, Fujio M, Sullivan BA, Kinjo Y, Kronenberg M, Wilson IA, Wong CH (2006) Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A 103:3972–3977PubMedPubMedCentralCrossRefGoogle Scholar
  177. Ye L, Wang X, Wang S, Wang Y, Song L, Hou W, Zhou L, Li H, Ho W (2009) CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Hepatology 49:753–762PubMedPubMedCentralCrossRefGoogle Scholar
  178. Yuan W, Kang SJ, Evans JE, Cresswell P (2009) Natural lipid ligands associated with human CD1d targeted to different subcellular compartments. J Immunol 182:4784–4791PubMedPubMedCentralCrossRefGoogle Scholar
  179. Zajonc DM, Girardi E (2015) Recognition of microbial glycolipids by natural killer T cells. Front Immunol 6:400PubMedPubMedCentralCrossRefGoogle Scholar
  180. Zajonc DM, Elsliger MA, Teyton L, Wilson IA (2003) Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. Nat Immunol 4:808–815PubMedCrossRefGoogle Scholar
  181. Zajonc DM, Crispin MD, Bowden TA, Young DC, Cheng TY, Hu J, Costello CE, Rudd PM, Dwek RA, Miller MJ, Brenner MB, Moody DB, Wilson IA (2005a) Molecular mechanism of lipopeptide presentation by CD1a. Immunity 22:209–219PubMedCrossRefGoogle Scholar
  182. Zajonc DM, Maricic I, Wu D, Halder R, Roy K, Wong CH, Kumar V, Wilson IA (2005b) Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med 202:1517–1526PubMedPubMedCentralCrossRefGoogle Scholar
  183. Zeissig S, Dougan SK, Barral DC, Junker Y, Chen Z, Kaser A, Ho M, Mandel H, McIntyre A, Kennedy SM, Painter GF, Veerapen N, Besra GS, Cerundolo V, Yue S, Beladi S, Behar SM, Chen X, Gumperz JE, Breckpot K, Raper A, Baer A, Exley MA, Hegele RA, Cuchel M, Rader DJ, Davidson NO, Blumberg RS (2010) Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J Clin Invest 120:2889–2899PubMedPubMedCentralCrossRefGoogle Scholar
  184. Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A, Bosse E, Iqbal J, Hussain MM, Balschun K, Rocken C, Arlt A, Gunther R, Hampe J, Schreiber S, Baron JL, Moody DB, Liang TJ, Blumberg RS (2012) Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 18:1060–1068PubMedPubMedCentralCrossRefGoogle Scholar
  185. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA (1997) Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277:339–345PubMedCrossRefGoogle Scholar
  186. Zhang G, Nie H, Yang J, Ding X, Huang Y, Yu H, Li R, Yuan Z, Hu S (2011) Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol 301:L975–L984PubMedCrossRefGoogle Scholar
  187. Zhao J, Weng X, Bagchi S, Wang CR (2014) Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response. Proc Natl Acad Sci U S A 111:2674–2679PubMedPubMedCentralCrossRefGoogle Scholar
  188. Zhao J, Siddiqui S, Shang S, Bian Y, Bagchi S, He Y, Wang CR (2015) Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model. Elife 4:e08525Google Scholar
  189. Zhou D, Cantu C 3rd, Sagiv Y, Schrantz N, Kulkarni AB, Qi X, Mahuran DJ, Morales CR, Grabowski GA, Benlagha K, Savage P, Bendelac A, Teyton L (2004a) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303:523–527PubMedCrossRefGoogle Scholar
  190. Zhou D, Mattner J, Cantu C 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A (2004b) Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786–1789PubMedCrossRefGoogle Scholar
  191. Zinkernagel RM, Doherty PC (1974) Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 251:547–548PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Department of Environmental HealthUniversity of Cincinnati College of MedicineCincinnatiUSA
  2. 2.Divison of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations